The Pharmacy Group’s Chief Executive Officer Perry Cohen recently moderated a panel discussion for Managed Healthcare Executive on the exponential growth and spending on Specialty Pharmaceuticals, on which spending could Quadruple by 2020 (UnitedHealth Group).
The panel consisted of experts from different sections of the industry, with discussion focused on challenges and potential solutions.
The panel consisted of:
- Ken Schaecher, MD, medical director, SelectHealth
- David Calabrese, RPh, MHP, chief pharmacy officer, OptumRx
- Bobby Dubois, MD, PhD, chief science officer, National Pharmaceutical Council
- Cheryl Larson, vice president, Midwest Business Group on Health
Click here to read more about the panels’ suggested solutions for managing the rising costs of Specialty Pharmacy Drugs.